Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Obama opens U.S. to pharma trade with Cuba

by Glenn Hess
October 24, 2016 | A version of this story appeared in Volume 94, Issue 42

The Obama Administration’s newest round of executive actions designed to increase trade between the U.S. and Cuba will eventually allow pharmaceuticals made on the island to be sold in the U.S. In another change, U.S. scientists will be allowed to work on joint medical research projects alongside their Cuban counterparts. “Their biomedical industry is one that has a lot to offer to the American market,” says Ricardo Herrero, the executive director of #CubaNow, a Miami-based group that supports U.S. engagement with Cuba. Under the new measures, Cuban pharmaceutical companies may apply for U.S. regulatory approval and U.S. firms will be allowed to import, market, and sell FDA-approved Cuban-origin drugs. Cuba has patented about 400 pharmaceuticals. The new rules, issued by the U.S. Departments of the Treasury and of Commerce, also lift the $100 limit on rum and cigars that U.S. travelers can bring back from the island.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.